Higami Hirooki, Toyofuku Mamoru, Morimoto Takeshi, Ohya Masanobu, Fuku Yasushi, Yamaji Kyohei, Muranishi Hiromi, Yamaji Yuhei, Nishida Koji, Furukawa Daisuke, Tada Tomohisa, Ko Euihong, Ando Kenji, Sakamoto Hiroki, Tamura Takashi, Kawai Kazuya, Kadota Kazushige, Kimura Takeshi
Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Japanese Red Cross Society Wakayama Medical Centre, Wakayama, Japan.
Cardiovasc Interv Ther. 2018 Oct;33(4):350-359. doi: 10.1007/s12928-017-0497-2. Epub 2017 Oct 19.
We hypothesized that patients who had previous target-lesion revascularization (TLR) for DES restenosis in non-left main coronary artery (LMCA) lesions might have a higher risk for restenosis after subsequent DES implantation for a de novo unprotected LMCA lesion. Among 1809 patients enrolled in the Assessing Optimal Percutaneous Coronary Intervention for LMCA (AOI-LMCA) registry, which is a retrospective 6-centre registry of consecutive patients undergoing LMCA stenting in Japan, 251 patients with previous DES implantation for non-LMCA lesions were subdivided into the 2 groups with (N = 56) or without (N = 195) previous TLR in non-LMCA lesions. The risk for TLR for LMCA was neutral between the prior TLR for DES restenosis group and the no prior TLR for DES restenosis group [hazard ratio (HR) 0.99, 95% confidence interval (CI) 0.44-2.02, P = 0.98]. The risks for both TLR caused by restenosis of the LMCA main branch, and second TLR for restenosis after first TLR for LMCA were also neutral between the 2 groups (HR 0.42, 95% CI 0.10-1.25, P = 0.13, and HR 0.59, 95% CI 0.03-3.63, P = 0.60, respectively). In conclusion, prior TLR for DES restenosis in non-LMCA lesions was not associated with worse long-term clinical outcomes after DES implantation for de novo unprotected LMCA lesions.
Assessing Optimal Percutaneous Coronary Intervention for Left Main Coronary Artery Stenting Registry (AOI LMCA Stenting Registry). http://www.umin.ac.jp/ctr/index/htm/ . Unique Identifier: UMIN000014706.
我们假设,对于非左主干冠状动脉(LMCA)病变的药物洗脱支架(DES)再狭窄进行过靶病变血管重建术(TLR)的患者,在随后针对新出现的无保护LMCA病变植入DES后,再狭窄风险可能更高。在评估LMCA的最佳经皮冠状动脉介入治疗(AOI-LMCA)注册研究中纳入的1809例患者中,该研究是日本一项对连续接受LMCA支架置入术患者进行的回顾性6中心注册研究,251例先前因非LMCA病变植入DES的患者被分为两组,即非LMCA病变有(N = 56)或无(N = 195)先前TLR的患者。LMCA的TLR风险在DES再狭窄先前TLR组和DES再狭窄无先前TLR组之间呈中性[风险比(HR)0.99,95%置信区间(CI)0.44 - 2.02,P = 0.98]。两组之间,由LMCA主支再狭窄引起的TLR风险以及LMCA首次TLR后再狭窄的第二次TLR风险也呈中性(HR分别为0.42,95% CI 0.10 - 1.25,P = 0.13,以及HR 0.59,95% CI 0.03 - 3.63,P = 0.60)。总之,非LMCA病变的DES再狭窄先前TLR与新出现的无保护LMCA病变植入DES后的长期临床结局较差无关。
评估左主干冠状动脉支架置入术的最佳经皮冠状动脉介入治疗注册研究(AOI LMCA支架置入注册研究)。http://www.umin.ac.jp/ctr/index/htm/ 。唯一标识符:UMIN000014706。